APA (7th ed.) Citation

A, A., S, P., J, M., J, F., S, J., A, L., . . . DM, P. (2026). Ephrin-A1/EphA2 modulates vascular smooth muscle cell proliferation in vitro, while VSMC-specific ephrin-A1 deletion is not sufficient to alter arteriosclerosis in vivo. Biochimica et biophysica acta. Molecular cell research, 1873(2), 120098. https://doi.org/10.1016/j.bbamcr.2025.120098

Chicago Style (17th ed.) Citation

A, Augstein, Porth S, Mierke J, Friedrich J, Jellinghaus S, Linke A, Adams V, and Poitz DM. "Ephrin-A1/EphA2 Modulates Vascular Smooth Muscle Cell Proliferation in Vitro, While VSMC-specific Ephrin-A1 Deletion Is Not Sufficient to Alter Arteriosclerosis in Vivo." Biochimica Et Biophysica Acta. Molecular Cell Research 1873, no. 2 (2026): 120098. https://doi.org/10.1016/j.bbamcr.2025.120098.

MLA (9th ed.) Citation

A, Augstein, et al. "Ephrin-A1/EphA2 Modulates Vascular Smooth Muscle Cell Proliferation in Vitro, While VSMC-specific Ephrin-A1 Deletion Is Not Sufficient to Alter Arteriosclerosis in Vivo." Biochimica Et Biophysica Acta. Molecular Cell Research, vol. 1873, no. 2, 2026, p. 120098, https://doi.org/10.1016/j.bbamcr.2025.120098.